Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model

Antiviral Research

Volumn 99, Issue 2, 2013, Pages 188-195

  Gualdi, Lucien ^a   Mertz, Sara ^a   Gomez, Ana M ^b   Ramilo, Octavio ^a   Wittke, Anja ^c   Mejias, Asuncion ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Pediatric Cardiothoracic Surgery   (United States)

^c Mead Johnson Nutritionals   (United States)

Author keywords

Bovine lactoferrin; Breast feeding; Disease severity; RSV

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LACTOFERRIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; COW; DISEASE SEVERITY; IN VIVO STUDY; INDEPENDENT COMPONENT ANALYSIS; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH1 CELL; TH17 CELL; TH2 CELL; VIRUS REPLICATION; WEIGHT REDUCTION;

BOVINE LACTOFERRIN; BREAST FEEDING; DISEASE SEVERITY; RSV;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIVIRAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LACTOFERRIN; LUNG; MICE; MICE, INBRED BALB C; PNEUMONIA; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL LOAD; VIRUS REPLICATION;

BOVINAE; EQUUS ASINUS; MURINAE; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84879199849     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.05.013     Document Type: Article

References (41)

1. Andersen J.H., Osbakk S.A., Vorland L.H., Traavik T., Gutteberg T.J. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res. 2001, 51:141-149.
2. Beaudry M., Dufour R., Marcoux S. Relation between infant feeding and infections during the first six months of life. J. Pediatr. 1995, 126:191-197.
3. Bennett R.M., Kokocinski T. Lactoferrin content of peripheral blood cells. Br. J. Haematol. 1978, 39:509-521.
4. Berlutti F., Pilloni A., Pietropaoli M., Polimeni A., Valenti P. Lactoferrin and oral diseases: current status and perspective in periodontitis. Ann. Stomatol. (Roma) 2011, 2:10-18.
5. Bloemers B.L., van Furth A.M., Weijerman M.E., Gemke R.J., Broers C.J., et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis - a prospective birth-cohort study. Pediatrics 2007, 120:e1076-81.
6. Dixon D.L., Griggs K.M., Forsyth K.D., Bersten A.D. Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronchiolitis. Pediatr. Allergy Immunol. 2010, 21:e691-e696.
7. Estripeaut D., Torres J.P., Somers C.S., Tagliabue C., Khokhar S., et al. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J. Infect. Dis. 2008, 198:1435-1443.
8. Fujihara T., Hayashi K. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch. Virol. 1995, 140:1469-1472.
9. Furlund C.B., Kristoffersen A.B., Devold T.G., Vegarud G.E., Jonassen C.M. Bovine lactoferrin digested with human gastrointestinal enzymes inhibits replication of human echovirus 5 in cell culture. Nutr. Res. 2012, 32:503-513.
10. Garcia C.G., Bhore R., Soriano-Fallas A., Trost M., Chason R., et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 2010, 126:e1453-60.
11. Gonzalez-Chavez S.A., Arevalo-Gallegos S., Rascon-Cruz Q. Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents 2009, 33(301):e1-8.
12. Grover M., Giouzeppos O., Schnagl R.D., May J.T. Effect of human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus. Acta Paediatr. 1997, 86:315-316.
13. Hall C.B., Weinberg G.A., Iwane M.K., Blumkin A.K., Edwards K.M., et al. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 2009, 360:588-598.
14. Hasegawa K., Motsuchi W., Tanaka S., Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 1994, 47:73-85.
15. Ikeda M., Nozaki A., Sugiyama K., Tanaka T., Naganuma A., et al. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res. 2000, 66:51-63.
16. Ikeda M., Sugiyama K., Tanaka T., Tanaka K., Sekihara H., et al. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun. 1998, 245:549-553.
17. Jafri H.S., Chavez-Bueno S., Mejias A., Gomez A.M., Rios A.M., et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J. Infect. Dis. 2004, 189:1856-1865.
18. Klein M.I., Bergel E., Gibbons L., Coviello S., Bauer G., et al. Differential gender response to respiratory infections and to the protective effect of breast milk in preterm infants. Pediatrics 2008, 121:e1510-6.
19. Kuhara T., Yamauchi K., Tamura Y., Okamura H. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J. Interferon. Cytokine Res. 2006, 26:489-499.
20. Legrand D. Lactoferrin, a key molecule in immune and inflammatory processes. Biochem. Cell Biol. 2012, 90:252-268.
21. Legrand D., Elass E., Carpentier M., Mazurier J. Interactions of lactoferrin with cells involved in immune function. Biochem. Cell Biol. 2006, 84:282-290.
22. Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur. J. Haematol. 1996, 56:263-277.
23. Li X.J., Liu D.P., Chen H.L., Pan X.H., Kong Q.Y., Pang Q.F. Lactoferrin protects against lipopolysaccharide-induced acute lung injury in mice. Int. Immunopharmacol. 2012, 12:460-464.
24. Lopez-Alarcon M., Villalpando S., Fajardo A. Breast-feeding lowers the frequency and duration of acute respiratory infection and diarrhea in infants under six months of age. J. Nutr. 1997, 127:436-443.
25. Manzoni P., Rinaldi M., Cattani S., Pugni L., Romeo M.G., et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009, 302:1421-1428.
26. Mejias A., Chavez-Bueno S., Rios A.M., Saavedra-Lozano J., Fonseca Aten M. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob. Agents Chemother. 2004, 48:1811-1822.
27. Mella C., Suarez-Arrabal M.C., Lopez S., Stephens J., Fernandez S., et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2013, 207:564-573.
28. Metz-Boutigue M.H., Jolles J., Mazurier J., Schoentgen F., Legrand D., et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 1984, 145:659-676.
29. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
30. Portelli J., Gordon A., May J.T. Effect of compounds with antibacterial activities in human milk on respiratory syncytial virus and cytomegalovirus in vitro. J. Med. Microbiol. 1998, 47:1015-1018.
31. Puddu P., Borghi P., Gessani S., Valenti P., Belardelli F., Seganti L. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int. J. Biochem. Cell Biol. 1998, 30:1055-1062.
32. Rios A.M., Mejias A., Chavez-Bueno S., Fonseca-Aten M., Katz K., et al. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Antimicrob. Agents Chemother. 2004, 48:2897-2904.
33. Sano H., Nagai K., Tsutsumi H., Kuroki Y. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur. J. Immunol. 2003, 33:2894-2902.
34. Shay D.K., Holman R.C., Newman R.D., Liu L.L., Stout J.W., Anderson L.J. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999, 282:1440-1446.
35. Shestakov A., Jenssen H., Nordstrom I., Eriksson K. Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice. Antiviral Res. 2012, 93:340-345.
36. Shin K., Wakabayashi H., Yamauchi K., Teraguchi S., Tamura Y., et al. Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice. J. Med. Microbiol. 2005, 54:717-723.
37. Superti F., Ammendolia M.G., Valenti P., Seganti L. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. 1997, 186:83-91.
38. Torres J.P., Gomez A.M., Khokhar S., Bhoj V.G., Tagliabue C., et al. Respiratory Syncytial Virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice. Respir. Res. 2010, 11:125.
39. Wang E.E., Law B.J., Boucher F.D., Stephens D., Robinson J.L., et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J. Pediatr. 1996, 129:390-395.
40. Welliver R.C., Hintz K.M., Shalwitz R.M. Lactoferrin reverses respiratory abnormalities in respiratory syncytial virus (rsv) infection of mice. Pediatric Res. 1999, 45:178A.
41. Zuccotti G.V., Trabattoni D., Morelli M., Borgonovo S., Schneider L., Clerici M. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. J. Biol. Regul. Homeost. Agents 2009, 23:119-123.